Stay updated on Apatinib Plus Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the Apatinib Plus Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Apatinib Plus Pembrolizumab Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    yesterday
    No Change Detected
  3. Check
    3 days ago
    Change Detected
    Summary
    The value of Revision has been updated from v2.8.0 to v2.8.1, indicating a recent revision in the content of the webpage.
    Difference
    0.1%
    Check dated 2024-06-13T21:12:06.000Z thumbnail image
  4. Check
    4 days ago
    No Change Detected
  5. Check
    5 days ago
    No Change Detected
  6. Check
    10 days ago
    Change Detected
    Summary
    The value on the webpage has changed from 7 to 8, indicating a recent update in the study details of the open label nonrandomized Phase I/IIA trial assessing the safety, tolerability, and efficacy of apatinib in combination with pembrolizumab for patients with advanced malignancies.
    Difference
    0.1%
    Check dated 2024-06-06T14:28:52.000Z thumbnail image
  7. Check
    25 days ago
    Change Detected
    Summary
    The webpage has updated the 'Participation Criteria' section to provide detailed eligibility criteria for participants, including specific health conditions and prior treatments required for inclusion in the study. Previously, no information was provided in this section.
    Difference
    50%
    Check dated 2024-05-22T20:59:16.000Z thumbnail image
  8. Check
    46 days ago
    Change Detected
    Difference
    0.9%
    Check dated 2024-04-30T22:55:15.000Z thumbnail image

Stay in the know with updates to Apatinib Plus Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Apatinib Plus Pembrolizumab Clinical Trial page.